Pharmacological targeting of the NLRP3 inflammasome in pre-clinical models of Parkinson's disease using a potent orally active inhibitor (2015–2017)

Grant type:
The Michael J Fox Foundation for Parkinsons Research
Researchers:
Funded by:
The Michael J Fox Foundation for Parkinsons Research